深圳国华网安科技股份有限公司关于对中山润乐药业有限公司增资的进展公告

Investment Overview - Shenzhen Guohua Network Security Technology Co., Ltd. approved a capital increase of 1.04 million RMB to Zhongshan Runle Pharmaceutical Co., Ltd. through its subsidiary, Shenzhen Guoke Zhijian Pharmaceutical Co., Ltd. [1] - The decision was made during the 12th Board of Directors meeting on December 1, 2025, and further details were disclosed on December 2, 2025 [1]. Progress of Investment - As of the announcement date, Runle Pharmaceutical has completed the registration change and received a new business license from the Zhongshan Market Supervision Administration [2]. - The registered capital of Runle Pharmaceutical has increased to 2.04 million RMB, with Guoke Zhijian holding 50.9804% of the shares, thus consolidating Runle Pharmaceutical into the company's financial statements [2]. Company Information - Company Name: Zhongshan Runle Pharmaceutical Co., Ltd. [4] - Unified Social Credit Code: 91440112MAE9DGMY39 [4] - Legal Representative: Huang Xiang [4] - Company Type: Other limited liability company [4] - Establishment Date: January 27, 2025 [4] - Registered Capital: 2.04 million RMB [4] - Address: 4th Floor, No. 3 Building, Yongning Huaye Road, Xiaolan Town, Zhongshan City [4].